LinaGGilletYVandeneschF. Toxin involvement in staphylococcal-scalded-skin syndrome. Clin Infect Dis1997; 25:1369–1373.
2.
AmonRBDimondRL. Toxic epidermal necrolysis: Rapid differentiation between staphylococcal- and drug-induced disease. Arch Dermatol1975; 111:1433–1437.
3.
YarbroughDR3rd. Experience with toxic epidermal necrolysis in a burn center. J Burn Care Rehabil1996; 17:30–33.
4.
RevuzJERoujeauJC. Advances in toxic epidermal necrolysis. Sem Cutan Med Surg1996; 15:258–266.
5.
KhooAKFooCL. Toxic epidermal necrolysis in a burns center: A 6-year review. Burns1996; 22:275–278.
6.
RoujeauJ-CKellyJPNaldiL. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med1995; 333:1600–1607.
7.
IttmannPIBozynskiMEA. Toxic epidermal necrolysis in a newborn infant after exposure to adhesive remover. J Perinatol1993; 13:476–477.
8.
GuillaumeJ-CRoujeauJ-CRevuzJ. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol1987; 123:1166–1170.
9.
Azon-MasoliverAVilaplanaJ. Fluconazole-induced toxic epidermal necrolysis in a patient with human immunodeficiency virus infection. Dermatology1993; 187:268–269.
10.
ThomasonJL. Clinical evaluation of terconazole: United States experience. J Reproduct Med1989; 8(Suppl):597–601.
11.
WeisbergM. Terconazole—a new antifungal agent for vulvovaginal candidiasis. Clin Ther1989; 5:659–668.
12.
MoebiusUM. Influenza-like syndrome after terconazole. Lancet1988; ii:966–967.
13.
GeigerAJ. Influenza-like syndrome after terconazole. Lancet1988; ii:1192.
14.
HyderSSManjonJEGantzNM. Fever and leukocytosis related to terconazole vaginal suppository. South Med J1994; 87: 762–763.
15.
GriffithsJKDalyJSDodgeRA. Two cases of endocarditis due to Lactobacillus species: Antimicrobial susceptibility, review, and discussion of therapy. Clin Infect Dis1992; 15:250–255.